EBITDA Margin % is calculated as EBITDA divided by its Revenue. Zynex's EBITDA for the
three
months ended in Mar. 2024 was $1.6 Mil. Zynex's Revenue for the
three
months ended in Mar. 2024 was $46.5 Mil. Therefore, Zynex's EBITDA margin for the quarter that ended in Mar. 2024 was 3.49%.
Zynex EBITDA Margin % Historical Data
The historical data trend for Zynex's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Zynex's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zynex's EBITDA Margin % Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zynex's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Zynex's EBITDA Margin % falls into.
Zynex EBITDA Margin % Calculation
EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.
Zynex's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zynex (NAS:ZYXI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Zynex EBITDA Margin % Related Terms
Thank you for viewing the detailed overview of Zynex's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZYXI has been successfully added to your 